Renal physiology of nocturia

Area of Science:

• Nephrology
• Endocrinology
• Urology

Background:

• Arginine vasopressin (AVP) regulates kidney water excretion and influences urine formation.
• Diurnal variations in AVP secretion, sex, and aging significantly impact renal function and nocturia.
• AVP V2 receptors in the kidney collecting duct mediate AVP's renal effects, with low AVP levels showing greater sensitivity to changes.

Purpose of the Study:

• To explore the role of arginine vasopressin (AVP) in nocturia.
• To investigate the impact of diurnal AVP fluctuations, sex, and age on urine formation and nocturia.
• To consider renal physiological aspects in the prescription of antidiuretic drugs for nocturia.

Main Methods:

• Analysis of studies examining plasma AVP levels in patients with and without nocturia.
• Consideration of the genetic location of the V2 receptor gene (X chromosome) and its sex-specific implications.
• Evaluation of age-related changes in water metabolism, including extracellular fluid, plasma volume, and renal function.

Main Results:

• Patients with nocturia showed no significant variation in plasma AVP, unlike controls with significant diurnal variation.
• Mutations in the V2 receptor gene predominantly affect men, causing nephrogenic diabetes insipidus.
• Aging is associated with reduced renal function, impaired urine concentration, decreased thirst perception, and potential AVP hypersecretion, increasing risks.

Conclusions:

• Disrupted diurnal AVP variation is a key factor in nocturia.
• Sex and advanced age significantly influence AVP regulation and renal water handling, impacting nocturia.
• Understanding these physiological factors is crucial for effective antidiuretic drug therapy in nocturia patients.